Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls
Open Access
- 1 August 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 8 (8) , 1396-1405
Abstract
Summary: Background and objectives: Cell-based therapy with natural (CD4+CD25hiCD127lo) regulatory T cells to induce transplant tolerance is now technically feasible. However, regulatory T cells from hemodialysis patients awaiting transplantation may be functionally/numerically defective. Human regulatory T cells are also heterogeneous, and some are able to convert to proinflammatory Th17 cells. This study addresses the suitability of regulatory T cells from hemodialysis patients for cell-based therapy in preparation for the first clinical trials in renal transplant recipients (the ONE Study). Design, setting, participants, & measurements: Healthy controls and age- and sex-matched hemodialysis patients without recent illness/autoimmune disease on established, complication-free hemodialysis for a minimum of 6 months were recruited. Circulating regulatory T cells were studied by flow cytometry to compare the regulatory T cell subpopulations. Regulatory T cells from members of each group were compared for suppressive function and plasticity (IL-17–producing capacity) before and after in vitro expansion with and without Rapamycin, using standard assays. Results: Both groups had similar total regulatory T cells and subpopulations I and III. In each subpopulation, regulatory T cells expressed similar levels of the function-associated markers CD27, CD39, HLA-DR, and FOXP3. Hemodialysis regulatory T cells were less suppressive, expanded poorly compared with healthy control regulatory T cells, and produced IL-17 in the absence of Rapamycin. However, Rapamycin efficiently expanded hemodialysis regulatory T cells to a functional and stable cell product. Conclusions: Rapamycin-based expansion protocols should enable clinical trials of cell-based immunotherapy for the induction of tolerance to renal allografts using hemodialysis regulatory T cells.Keywords
This publication has 50 references indexed in Scilit:
- 1,25-Dihydroxyvitamin D 3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17AMolecular and Cellular Biology, 2011
- Spatial Coupling of mTOR and Autophagy Augments Secretory PhenotypesScience, 2011
- Massive ex Vivo Expansion of Human Natural Regulatory T Cells (T regs ) with Minimal Loss of in Vivo Functional ActivityScience Translational Medicine, 2011
- Ex Vivo–Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse ModelTransplantation, 2010
- In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cellsNature Medicine, 2010
- Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T CellsScience, 2010
- Translational Mini-Review Series on Th17 Cells: Induction of interleukin-17 production by regulatory T cellsClinical and Experimental Immunology, 2009
- Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to RapamycinPLOS ONE, 2009
- Oxidized LDL Modulates Apoptosis of Regulatory T Cells in Patients with ESRDJournal of the American Society of Nephrology, 2009
- The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significancePurinergic Signalling, 2006